Electroencephalogram During Desflurane Anaesthesia

November 24, 2014 updated by: Arvi Yli-Hankala, Tampere University Hospital

Electroencephalogram During Increasing and Decreasing Desflurane Concentration

To study the behavior of EEG during changing desflurane concentrations.

Study Overview

Status

Withdrawn

Conditions

Intervention / Treatment

Detailed Description

The concentration of desflurane will be increased to burst suppression EEG level, and thereafter decreased.

Study Type

Interventional

Phase

  • Phase 4

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 80 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • adult patients

Exclusion Criteria:

  • pediatric patients

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Diagnostic
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: desflurane
inhalation concentration
Other: desflurane
changing concentration

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The behavior of EEG indices numbers during the course of anesthesia, with comparison to raw EEG traces
Time Frame: participants will be followed for the duration of surgical anesthesia, an expected average of 1 hour
How do the EEG indices reflect the clinical evaluation of anesthetic state and the visual appearance of EEG
participants will be followed for the duration of surgical anesthesia, an expected average of 1 hour

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Tampere University Hospital

Investigators

  • Principal Investigator: Arvi M Yli-Hankala, MD, Tampere University Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

January 1, 2010

Primary Completion (Actual)

February 1, 2010

Study Completion (Actual)

February 1, 2010

Study Registration Dates

First Submitted

October 8, 2013

First Submitted That Met QC Criteria

January 27, 2014

First Posted (Estimate)

January 29, 2014

Study Record Updates

Last Update Posted (Estimate)

November 25, 2014

Last Update Submitted That Met QC Criteria

November 24, 2014

Last Verified

November 1, 2014

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • Kotoe _ 2
  • 2009-014620-36 (EudraCT Number)

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Anesthesia

Clinical Trials on desflurane

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Cameroon

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe